mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |